U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 3C2H3O2.Al
Molecular Weight 204.1136
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Aluminum acetate

SMILES

[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O

InChI

InChIKey=WCOATMADISNSBV-UHFFFAOYSA-K
InChI=1S/3C2H4O2.Al/c3*1-2(3)4;/h3*1H3,(H,3,4);/q;;;+3/p-3

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum sulfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

Originator

Curator's Comment: Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DOMEBORO

Approved Use

Temporarily relieves minor skin irritations due to: – Poison ivy | – Poison oak – Poison sumac | – Insect bites – Athlete’s foot | – Rashes caused by soaps, detergents, cosmetics, or jewelry
Curative
DOMEBORO

Approved Use

This medication is used to treat an outer ear infection (external otitis). This product contains acetic acid/aluminum acetate, a combination that stops the growth of bacteria and fungus. Treating the infection reduces pain and swelling in the ear. Wetness in the ear canal can help bacteria and fungus to grow. This medication also causes drying of the ear canal, helping to cure the infection.
PubMed

PubMed

TitleDatePubMed
The ineffectiveness of aluminum subacetate in rheumatoid arthritis.
1948 Apr 8
Cardiovascular manifestations of aluminium phosphide intoxication.
1989 Sep
Plasma renin activity in shock due to aluminium phosphide poisoning.
1990 Jun
Hypermagnesemia following aluminum phosphide poisoning.
1991 Feb
Effect of aluminum phosphide on blood glucose level.
1999 Feb
Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study.
1999 May
Intravascular hemolysis in aluminium phosphide poisoning.
1999 Sep
Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats.
2001 Apr
Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride.
2001 Jan
Bone cell mitogenic action of fluoroaluminate and aluminum fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system.
2002 May
Aluminum inclusion macrophagic myofasciitis: a recently identified condition.
2003 Nov
Aluminum: new recognition of an old problem.
2005 Dec
Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases.
2005 Nov
Cytochrome-c oxidase inhibition in 26 aluminum phosphide poisoned patients.
2006
Aluminum and Alzheimer's disease, a personal perspective after 25 years.
2006
Some aspects of astroglial functions and aluminum implications for neurodegeneration.
2006 Aug 30
Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
2006 Nov
Aluminum and Alzheimer's disease: a new look.
2006 Nov
The role of aluminum and copper on neuroinflammation and Alzheimer's disease.
2006 Nov
Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease.
2006 Nov
Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
2007 Oct
Reversible myocardial injury associated with aluminum phosphide poisoning.
2007 Sep
Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet.
2007 Sep-Oct
Hyperglycemia in acute aluminum phosphide poisoning as a potential prognostic factor.
2008 Jul
Aluminum phosphide fatalities at mild exertion in asymptomatic children: a clue to understand the variations of the autopsy findings.
2009 Aug
Altered glucose homeostasis in response to aluminium phosphide induced cellular oxygen deficit in rat.
2010 Jul
Blood levels of methemoglobin in patients with aluminum phosphide poisoning and its correlation with patient's outcome.
2011 Mar
Effect of acute aluminum phosphide exposure on rats: a biochemical and histological correlation.
2012 Nov 23
New insight into artifactual phenomena during in vitro toxicity assessment of engineered nanoparticles: study of TNF-α adsorption on alumina oxide nanoparticle.
2013 Apr
1H NMR spectroscopic analysis detects metabolic disturbances in rat urine on acute exposure to heavy metal tungsten alloy based metals salt.
2014 Mar 25
Pesticide exposure and depression among male private pesticide applicators in the agricultural health study.
2014 Sep
Molecular basis of carcinogenicity of tungsten alloy particles.
2015 Mar 15
Patents

Sample Use Guides

DOMEBORO® SOOTHING SOAK – dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water – stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use For use as a soak: – soak affected area for 15 to 30 minutes as needed, or as directed by a doctor – repeat 3 times a day or as directed by a doctor – discard solution after each use. For use as a compress or wet dressing: – soak a clean, soft cloth in the solution. – apply cloth loosely to affected area for 15 to 30 minutes – repeat as needed or as directed by a doctor – discard solution after each use
Route of Administration: Topical
Burow's solution (13% aluminum subacetate) is active against S. aureus and P. aeruginosa, resulting in damage to the cell wall.
Name Type Language
Aluminum acetate
II   INCI   MI   ORANGE BOOK   USP   VANDF  
INCI  
Official Name English
ALUMINUM ACETATE [USP IMPURITY]
Common Name English
DOMEBORO
Brand Name English
ACETIC ACID, ALUMINUM SALT (3:1)
Common Name English
ALUMINUM ACETATE [II]
Common Name English
BOROFAIR COMPONENT ALUMINUM ACETATE
Common Name English
BURO-SOL
Brand Name English
ALUMINUM ACETATE [INCI]
Common Name English
ALUMINIUM ACETATE
MART.   WHO-DD  
Systematic Name English
ALUMINUM ACETATE COMPONENT OF BOROFAIR
Common Name English
ALUMINIUM ACETATE [MART.]
Common Name English
ALUMINUM ACETATE [ORANGE BOOK]
Common Name English
ALUMINUM ACETATE [VANDF]
Common Name English
Aluminium acetate [WHO-DD]
Common Name English
ACETIC ACID, ALUMINUM SALT
Common Name English
ALUMINUM ACETATE [MI]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 176.170
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
CFR 21 CFR 347.12
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
NCI_THESAURUS C28394
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
Code System Code Type Description
EVMPD
SUB12809MIG
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201015
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
MERCK INDEX
m1590
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID30890496
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
NCI_THESAURUS
C47387
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
DRUG CENTRAL
4998
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
CAS
139-12-8
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
MESH
C013396
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
DAILYMED
80EHD8I43D
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
DRUG BANK
DB14518
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
SMS_ID
100000077667
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
WIKIPEDIA
Aluminium triacetate
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
FDA UNII
80EHD8I43D
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
ECHA (EC/EINECS)
205-354-1
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY
RXCUI
17609
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY RxNorm
PUBCHEM
8757
Created by admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
PRIMARY